Sio Gene Therapies
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $71,562,000.
Profit Margin
| 2015 | 0 | 0 | |
|---|---|---|---|
| 2016 | 0 | -133.14M | |
| 2017 | 0 | -180.95M | |
| 2018 | 0 | -221.57M | |
| 2019 | 0 | -129.06M | |
| 2020 | 0 | -72.62M | |
| 2021 | 0 | -32.42M | |
| 2022 | 0 | -71.88M |
SIOX Income Statement (2015 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||
Research and development | 53.39M | 24.90M | 47.11M | 87.55M | 141.41M | 134.77M | 76.64M | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 71.56M | 42.19M | 69.17M | 127.01M | 213.31M | 180.49M | 133.16M | 0 |
Operating income | -72.26M | -34.30M | -67.81M | -127.01M | -213.31M | -180.49M | -133.16M | 0 |
Other income (expenses), net | 639K | 1.66M | -4.37M | 5.61M | 211K | -1.51M | 0 | 0 |
Income before tax | -71.62M | -32.63M | -72.19M | -128.93M | -220.65M | -182.01M | -133.16M | 0 |
Income tax expense | 259K | -212K | 438K | 133K | 921K | -1.06M | -17K | 0 |
Net income | -71.88M | -32.42M | -72.62M | -129.06M | -221.57M | -180.95M | -133.14M | 0 |
Earnings per share | ||||||||
Basic EPS | -0.98 | -0.62 | -2.93 | -8.02 | -16.51 | -14.6 | -11.28 | 0 |
Diluted EPS | -0.98 | -0.62 | -2.93 | -8.02 | -16.51 | -14.6 | -11.28 | 0 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |